المؤلفون: Campos Ramírez SE; Department of Medical Oncology, University Hospital Miguel Servet, Zaragoza, Spain., Gómez Mateo MC; Department of Pathology, University Hospital Miguel Servet, Zaragoza, Spain., Ruffini Egea SE; Department of Medical Oncology, University Hospital Miguel Servet, Zaragoza, Spain., Monreal Cepero ML; Department of Medical Oncology, University Hospital Miguel Servet, Zaragoza, Spain., Gómez Mugarza P; Department of Medical Oncology, University Hospital Miguel Servet, Zaragoza, Spain., Barriendos Sanz S; Department of Medical Oncology, University Hospital Miguel Servet, Zaragoza, Spain., Martinez Trufero J; Department of Medical Oncology, University Hospital Miguel Servet, Zaragoza, Spain.

المصدر: Translational cancer research [Transl Cancer Res] 2024 May 31; Vol. 13 (5), pp. 2564-2570. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101585958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2219-6803 (Electronic) Linking ISSN: 2218676X NLM ISO Abbreviation: Transl Cancer Res Subsets: PubMed not MEDLINE

المؤلفون: Moura DS; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain. dmoura@atbsarc.org.; Department of Oncology in University Hospital Fundación Jiménez Díaz,, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain. dmoura@atbsarc.org., Mondaza-Hernandez JL; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Sanchez-Bustos P; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain., Peña-Chilet M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain.; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain.; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, 41013, Seville, Spain., Cordero-Varela JA; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain., Lopez-Alvarez M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain., Carrillo-Garcia J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Martin-Ruiz M; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Romero-Gonzalez P; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Renshaw-Calderon M; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain., Ramos R; Pathology Department, Son Espases University Hospital, 07120, Mallorca, Spain., Marcilla D; Pathology Department, University Hospital Virgen del Rocio, 41013, Seville, Spain., Alvarez-Alegret R; Pathology Department, Miguel Servet University Hospital, 50009, Saragossa, Spain., Agra-Pujol C; Pathology Department, Gregorio Marañon Universitary Hospital, 28007, Madrid, Spain., Izquierdo F; Pathological Anatomy Service, Complejo Asistencial Universitario de León, 24071, Leon, Spain., Ortega-Medina L; Pathology Department, Hospital Clinico San Carlos, 28040, Madrid, Spain., Martin-Davila F; Pathology Department, Ciudad Real General Hospital, 13005, Ciudad Real, Spain., Hernandez-Leon CN; Pathology department, Canarias University Hospital, 38320, Santa Cruz de Tenerife, Spain., Romagosa C; Pathology department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Salgado MAV; Medical Oncology Department, Ramon y Cajal University Hospital, 28034, Madrid, Spain., Lavernia J; Medical Oncology Department, Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Bagué S; Pathology Department, Hospital de la Santa Creu i Sant Pau, 08025, Barcelona, Spain., Mayodormo-Aranda E; Pathology Department, Hospital Universitari i Politècnic la Fe, 46026, Valencia, Spain., Alvarez R; Medical Oncology Department, Gregorio Marañon Universitary Hospital, 28007, Madrid, Spain., Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Martinez-Trufero J; Medical Oncology Department, Miguel Servet University Hospital, 50009, Saragossa, Spain., Castilla-Ramirez C; Pathology Department, University Hospital Virgen del Rocio, 41013, Seville, Spain., Gutierrez A; Hematology Department, Son Espases University Hospital, 07120, Mallorca, Spain., Dopazo J; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013, Seville, Spain.; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain.; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, 41013, Seville, Spain.; INB-ELIXIR-es, FPS, Hospital Virgen del Rocío, 41013, Seville, Spain., Hindi N; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain.; General de Villalba University Hospital, 28400, Madrid, Spain., Garcia-Foncillas J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain.; General de Villalba University Hospital, 28400, Madrid, Spain., Martin-Broto J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28015, Madrid, Spain. jmartin@atbsarc.org.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain. jmartin@atbsarc.org.; General de Villalba University Hospital, 28400, Madrid, Spain. jmartin@atbsarc.org.; Department of Oncology in University Hospital Fundación Jiménez Díaz,, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain. jmartin@atbsarc.org.

المصدر: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 May 17; Vol. 81 (1), pp. 219. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Trabectedin*/pharmacology , Sarcoma*/drug therapy , Sarcoma*/pathology , Sarcoma*/genetics , Sarcoma*/metabolism , HMGA1a Protein*/metabolism , HMGA1a Protein*/genetics, Humans ; Animals ; Cell Line, Tumor ; Mice ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Drug Resistance, Neoplasm/genetics ; Drug Resistance, Neoplasm/drug effects ; TOR Serine-Threonine Kinases/metabolism ; Gene Expression Regulation, Neoplastic/drug effects ; Signal Transduction/drug effects ; Prognosis ; Female ; Leiomyosarcoma/drug therapy ; Leiomyosarcoma/pathology ; Leiomyosarcoma/genetics ; Leiomyosarcoma/metabolism ; Xenograft Model Antitumor Assays

المؤلفون: Hindi N; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital and Hospital General de Villalba, Madrid; Instituto de Investigación Sanitaria-Fundación Jimenez Díaz-UAM (IIS-FJD-UAM), Madrid, Spain. Electronic address: nhindi@atbsarc.org., Razak A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Rosenbaum E; Memorial Sloan Kettering Cancer Center, New York., Jonczak E; Department of Hematology Oncology, Miami University, Miami, USA., Hamacher R; Medical Oncology Department, West German Cancer Center, University Hospital Essen, Essen, Germany., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Bhadri VA; Medical Oncology Department, Chris O Brien Lifehouse, Sydney, Australia., Skryd A; Miller School of Medicine, University of Miami, Miami, USA., Brahmi M; Centre Leon Berard & University Claude Bernard Lyon 1, Lyon, France., Alshibany A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Jagodzinska-Mucha P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Bauer S; Medical Oncology Department, West German Cancer Center, University Hospital Essen, Essen, Germany., Connolly E; Medical Oncology Department, Chris O Brien Lifehouse, Sydney, Australia., Gelderblom H; Medical Oncology Department, Leiden University Medical Center, Leiden, The Netherlands., Boye K; Institute for Cancer Research, Oslo University Hospital, Oslo; Department of Oncology, Oslo University Hospital, Oslo, Norway., Henon C; Medical Oncology Department, Institut de Cancérologie Gustave Roussy, Villejuif, France., Bae S; Medical Oncology Department, Peter Mac Callum Center, Melbourne, Australia., Bogefors K; Department of Oncology, Skåne University Hospital and Lund University, Lund, Sweden., Vincenzi B; Medical Oncology Department, University Campus Bio-Medico, Rome, Italy., Martinez-Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza., Lopez-Martin JA; Medical Oncology Department, Hospital Universitario 12 de Octubre, Translational Oncology Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid., Redondo A; Medical Oncology Department, Hospital Universitario La Paz-IdiPAZ, Madrid., Valverde C; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona., Blay JY; Centre Leon Berard & University Claude Bernard Lyon 1, Lyon, France., Moura DS; Instituto de Investigación Sanitaria-Fundación Jimenez Díaz-UAM (IIS-FJD-UAM), Madrid, Spain., Gutierrez A; Hematology Department, Hospital Universitario Son Espases, Palma, Spain., Tap W; Memorial Sloan Kettering Cancer Center, New York., Martin-Broto J; Medical Oncology Department, Fundacion Jimenez Diaz University Hospital and Hospital General de Villalba, Madrid; Instituto de Investigación Sanitaria-Fundación Jimenez Díaz-UAM (IIS-FJD-UAM), Madrid, Spain.

المصدر: ESMO open [ESMO Open] 2023 Dec; Vol. 8 (6), pp. 102045. Date of Electronic Publication: 2023 Nov 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma, Alveolar Soft Part*/drug therapy , Sarcoma, Alveolar Soft Part*/pathology , Antineoplastic Agents*/therapeutic use, Adult ; Humans ; Child, Preschool ; Child ; Adolescent ; Young Adult ; Middle Aged ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies ; Protein Kinase Inhibitors/therapeutic use

المؤلفون: Campos F; Medical Oncology Department, Soft Tissue Sarcoma and Bone Tumors Reference Center, A.C. Camargo Cancer Center, São Paulo, Brazil; Hospital Municipal da Vila Santa Catarina/Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: fernando.campos@accamargo.org.br., Téres R; Medical Oncology Department, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Sebio A; Medical Oncology Department, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Bettim BB; International Center of Research CIPE, A.C. Camargo Cancer Center, Sao Paulo, Brazil., Martinez-Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.

المصدر: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2023 Dec; Vol. 35 (12), pp. e720-e727. Date of Electronic Publication: 2023 Sep 22.

نوع المنشور: Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: England NLM ID: 9002902 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-2981 (Electronic) Linking ISSN: 09366555 NLM ISO Abbreviation: Clin Oncol (R Coll Radiol) Subsets: MEDLINE

مواضيع طبية MeSH: Osteosarcoma*/drug therapy , Osteosarcoma*/surgery , Soft Tissue Neoplasms*/pathology , Bone Neoplasms*/drug therapy , Bone Neoplasms*/surgery, Humans ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Doxorubicin/therapeutic use ; Chemotherapy, Adjuvant

المؤلفون: Martin-Broto J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain. jmartin@atbsarc.org.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain. jmartin@atbsarc.org.; General de Villalba University Hospital, 28400, Madrid, Spain. jmartin@atbsarc.org., Martinez-Garcia J; Medical Oncology Department, University Hospital Virgen de la Arrixaca, 30120, Murcia, Spain., Moura DS; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., Redondo A; Department of Medical Oncology, Hospital Universitario La Paz-IdiPAZ, P. Castellana, 261, 28046, Madrid, Spain., Gutierrez A; Hematology Department, University Hospital Son Espases, 07120, Mallorca, Spain., Lopez-Pousa A; Medical Oncology Department, Sant Pau Hospital, 08025, Barcelona, Spain., Martinez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, 50009, Zaragoza, Spain., Sevilla I; Investigación Clínica y Traslacional en Cáncer/ Instituto de Investigaciones Biomédicas de Malaga (IBIMA)/ Hospitales Universitarios Regional y Virgen de la Victoria de Malaga, Malaga, Spain., Diaz-Beveridge R; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, 46026, Valencia, Spain., Solis-Hernandez MP; Medical Oncology Department, Central University Hospital of Asturias, 33011, Oviedo, Spain., Carnero A; Instituto de Biomedicina de Sevilla (IBiS; HUVR, CSIC, US), 41013, Sevilla, Spain., Perez M; Instituto de Biomedicina de Sevilla (IBiS; HUVR, CSIC, US), 41013, Sevilla, Spain.; Pathology Department, Virgen del Rocio University Hospital, 41013, Sevilla, Spain., Marcilla D; Pathology Department, Virgen del Rocio University Hospital, 41013, Sevilla, Spain., Garcia-Foncillas J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain., Romero P; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., Fernandez-Jara J; Radiology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain., Lopez-Lopez D; Instituto de Biomedicina de Sevilla (IBiS; HUVR, CSIC, US), 41013, Sevilla, Spain.; Computational Medicine Platform, Fundación progreso y salud (FPS), Hospital Virgen del Rocío, 41013, Seville, Spain.; Bioinformatics in Rare Diseases (BiER). Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Sevilla, Spain., Arribas I; Universitat de València - ERI-CES, 46010, Valencia, Spain., Hindi N; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain.; General de Villalba University Hospital, 28400, Madrid, Spain.

المصدر: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Oct 25; Vol. 8 (1), pp. 405. Date of Electronic Publication: 2023 Oct 25.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

مواضيع طبية MeSH: Lipopolysaccharides* , Sarcoma*/genetics, Adult ; Humans ; Piperazines/therapeutic use ; Piperazines/pharmacology ; RNA, Messenger ; Cyclin-Dependent Kinase 4/genetics ; Cyclin-Dependent Kinase Inhibitor p16/genetics ; Cyclin-Dependent Kinase Inhibitor p16/metabolism

المؤلفون: Martin-Broto J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain. jmartin@atbsarc.org.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain. jmartin@atbsarc.org.; General de Villalba University Hospital, 28400, Madrid, Spain. jmartin@atbsarc.org., Valverde C; Medical Oncology department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Hindi N; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain.; General de Villalba University Hospital, 28400, Madrid, Spain., Vincenzi B; Medical Oncology, University Campus Bio-Medico and Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy., Martinez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, 50009, Zaragoza, Spain., Grignani G; Medical Oncology Unit, Città della Salute e della Scienza Hospital, 10126, Turin, Italy., Italiano A; Medical Oncology department, Institute Bergonié, 33076, Bordeaux, France., Lavernia J; Medical Oncology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Vallejo A; Pathology department, Hospital Regional Universitario de Malaga, 29010, Malaga, Spain., Tos PD; Department of Medicine, School of Medicine, University of Padua, 35122, Padua, Italy., Le Loarer F; Pathology department, Institute Bergonié, 33076, Bordeaux, France., Gonzalez-Campora R; Pathology department, Hospital Quironsalud, 14004, Cordoba, Cordoba, Spain., Ramos R; Pathology department, University Hospital Son Espases, 07120, Mallorca, Spain., Hernández-Jover D; Radiology department, Sant Pau University Hospital, 08025, Barcelona, Spain., Gutierrez A; Hematology department, University Hospital Son Espases, 07120, Mallorca, Spain., Serrano C; Medical Oncology department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Monteagudo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Letón R; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Robledo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain., Moura DS; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., Martin-Ruiz M; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., López-Guerrero JA; Molecular Biology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Cruz J; Pathology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Fernandez-Serra A; Molecular Biology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Blay JY; Medicine Department, Centre Léon Bérard, 69008, Lyon, France., Fumagalli E; Medicine Department, Fondazione IRCCS - Istituto Nazionale dei Tumori, 20133, Milan, Italy., Martinez-Marin V; Department of Medical Oncology, Hospital Universitario La Paz-IdiPAZ, P. Castellana, 261, 28046, Madrid, Spain.

المصدر: Molecular cancer [Mol Cancer] 2023 Aug 09; Vol. 22 (1), pp. 127. Date of Electronic Publication: 2023 Aug 09.

نوع المنشور: Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Gastrointestinal Stromal Tumors*/drug therapy , Gastrointestinal Stromal Tumors*/genetics , Sarcoma*/drug therapy, Adult ; Humans ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-kit/genetics

المؤلفون: Rubió-Casadevall J; Medical Oncology Department, Institut Català d'Oncologia Girona, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Cirauqui Cirauqui B; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain., Martinez Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Plana Serrahima M; Medical Oncology Department, Institut Català d'Oncologia (ICO-Hospitalet), IDIBELL, Hospitalet de Llobregat, Llobregat, Spain., García Castaño A; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Carral Maseda A; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Iglesias Docampo L; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Pérez Segura P; Medical Oncology Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Ceballos Lenza I; Medical Oncology Department, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain., Gutiérrez Calderón V; UGCI Oncol. Hospital Universitario Regional y Virgen Victoria, IBIMA, Málaga, Spain., Fuster Salvà J; Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Pena Álvarez C; Medical Oncology Department, Centro Oncológico Galicia, A Coruña, Spain., Hernandez I; Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Del Barco Morillo E; Medical Oncology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain., Chaves Conde M; Medical Oncology Department, Hospital Universitario Virgen de Valme, Sevilla, Spain., Martínez Galán J; Medical Oncology Department, Hospital Universitario Virgen Nieves, Instituto de Investigación Biosanitaria ibs, Granada, Spain., Durán Sánchez M; Spanish Group of Head and Neck Cancer Treatment (TTCC), Madrid, Spain., Quiroga V; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain., Ortega E; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Mesia R; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain.; Spanish Group of Head and Neck Cancer Treatment (TTCC), Madrid, Spain.

المصدر: Frontiers in oncology [Front Oncol] 2023 Aug 01; Vol. 13, pp. 1226939. Date of Electronic Publication: 2023 Aug 01 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Martinez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Comin Orce A; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Gomez Mugarza P; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Barriendos Sanz S; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain., Ortega Izquierdo E; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain.

المصدر: Translational cancer research [Transl Cancer Res] 2023 Apr 28; Vol. 12 (4), pp. 692-696. Date of Electronic Publication: 2023 Apr 06.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101585958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2219-6803 (Electronic) Linking ISSN: 2218676X NLM ISO Abbreviation: Transl Cancer Res Subsets: PubMed not MEDLINE

المؤلفون: Martin-Broto J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain. jmartin@atbsarc.org.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain. jmartin@atbsarc.org.; General de Villalba University Hospital, 28400, Madrid, Spain. jmartin@atbsarc.org.; Autonomous University of Madrid, 28049, Madrid, Spain. jmartin@atbsarc.org., Redondo A; Department of Medical Oncology, Hospital Universitario La Paz, 28046, Madrid, Spain., Moura DS; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., Valverde C; Department of Medical Oncology, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Morales JM; Radiology Department, Virgen del Rocio University Hospital, 41013, Sevilla, Spain., Lopez-Pousa A; Medical Oncology Department, Sant Pau Hospital, 08025, Barcelona, Spain., Martinez-Trufero J; Medical Oncology Department, Miguel Servet University Hospital, 50009, Zaragoza, Spain., Gutierrez A; Hematology Department, University Hospital Son Espases, 07120, Mallorca, Spain., Díaz-Beveridge R; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, 46026, Valencia, Spain., Luna P; Medical Oncology Department, Son Espases University Hospital, 07120, Mallorca, Spain., Martinez-Marin V; Department of Medical Oncology, Hospital Universitario La Paz, 28046, Madrid, Spain., Marcilla D; Pathology Department, Virgen del Rocio University Hospital, 41013, Sevilla, Spain., Arribas I; Universitat de València, 46010, Valencia, Spain., Ledesma P; Sofpromed Investigacion Clinica SLU, 07009, Mallorca, Spain., Lopez-Martin JA; Medical Oncology Department, 12 de Octubre University Hospital, 28041, Madrid, Spain., Di Lernia D; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., Zamora J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., Hindi N; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, 28040, Madrid, Spain.; General de Villalba University Hospital, 28400, Madrid, Spain.; Autonomous University of Madrid, 28049, Madrid, Spain.

المصدر: Nature communications [Nat Commun] 2022 Oct 21; Vol. 13 (1), pp. 6278. Date of Electronic Publication: 2022 Oct 21.

نوع المنشور: Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Fibromatosis, Aggressive*/diagnostic imaging , Fibromatosis, Aggressive*/drug therapy , Fibromatosis, Aggressive*/chemically induced, Humans ; Paclitaxel/adverse effects ; Albumins/adverse effects ; Pain/drug therapy

المؤلفون: Moura DS; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain., Peña-Chilet M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain.; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, Seville, Spain.; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Seville, Spain., Cordero Varela JA; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain., Alvarez-Alegret R; Pathology Department, Miguel Servet University Hospital, Zaragoza, Spain., Agra-Pujol C; Pathology Department, Gregorio Marañon University Hospital, Madrid, Spain., Izquierdo F; Pathological Anatomy Service, Complejo Asistencial Universitario de León, Spain., Ramos R; Pathology Department, Son Espases University Hospital, Mallorca, Spain., Ortega-Medina L; Pathology Department, Hospital Clinico San Carlos, Madrid, Spain., Martin-Davila F; Pathology Department, Ciudad Real General Hospital, Spain., Castilla-Ramirez C; Pathology Department, University Hospital Virgen del Rocio, Seville, Spain., Hernandez-Leon CN; Pathology Department, Canarias University Hospital, Santa Cruz de Tenerife, Spain., Romagosa C; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Vaz Salgado MA; Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain., Lavernia J; Medical Oncology Department, Instituto Valenciano de Oncologia, Valencia, Spain., Bagué S; Pathology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Mayodormo-Aranda E; Pathology Department, Hospital Universitari i Politècnic la Fe, Valencia, Spain., Vicioso L; Pathology Department, Virgen de la Victoria University Hospital, Malaga, Spain., Hernández Barceló JE; Pathology Department, Virgen de la Arrixaca University Hospital, Murcia, Spain., Rubio-Casadevall J; Medical Oncology Department, Hospital Josep Trueta, Catalan Institute of Oncology, Girona, Spain., de Juan A; Medical Oncology Department, Marqués de Valdecilla University Hospital, Santander, Spain., Fiaño-Valverde MC; Department of Histopathology, Álvaro Cunqueiro Hospital, University Hospital Complex of Vigo, Spain., Hindi N; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain.; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain., Lopez-Alvarez M; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain., Lacerenza S; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain., Dopazo J; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain.; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, Seville, Spain.; Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Seville, Spain.; INB-ELIXIR-es, FPS, Hospital Virgen del Rocío, Seville, Spain., Gutierrez A; Hematology Department, Son Espases University Hospital, Mallorca, Spain., Alvarez R; Medical Oncology Department, Gregorio Marañon University Hospital, Madrid, Spain., Valverde C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Martinez-Trufero J; Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain., Martín-Broto J; Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Spain.; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain.; University Hospital General de Villalba, Madrid, Spain.; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain.

المصدر: Molecular oncology [Mol Oncol] 2021 Dec; Vol. 15 (12), pp. 3691-3705. Date of Electronic Publication: 2021 Jun 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma*/drug therapy , Sarcoma*/genetics , Tetrahydroisoquinolines*/adverse effects, Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; DNA Damage ; DNA Repair/genetics ; Dioxoles/adverse effects ; Humans ; Retrospective Studies ; Trabectedin/therapeutic use